Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-12-13Clinical Trial Update: Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia [Phase 4]
This Phase 4 trial update reports the completion of a study evaluating quetiapine (Seroquel) as therapy for substance use disorders in patie…
-
CLINICAL_TRIALS trial_result · 2007-11-27Clinical Trial Update: Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder [Phase 3]
A Phase 3 trial comparing rapid versus conventional titration of quetiapine in schizophrenia and schizoaffective disorder has been terminate…
-
CLINICAL_TRIALS trial_result · 2007-11-06Clinical Trial Update: Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder [Phase 4]
Phase 4 trial comparing continuing olanzapine to switching to quetiapine in overweight or obese adults with schizophrenia or schizoaffective…
-
CLINICAL_TRIALS trial_result · 2007-08-24Clinical Trial Update: Abilify Therapy for Reducing Comorbid Substance Abuse [Phase 4]
Phase 4 trial evaluating aripiprazole (Abilify) for reducing comorbid substance use across multiple psychiatric disorders; the study has com…
-
CLINICAL_TRIALS trial_result · 2007-08-23Clinical Trial Update: Effect of High-Dose B-Complex Vitamins on the Symptoms of Schizophrenia [NA]
This clinical trial evaluated whether high-dose B-complex vitamins improve symptoms in schizophrenia and schizoaffective disorder. The study…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-04-23Clinical Trial Update: The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study [Phase 2]
A Phase 2 pilot study evaluating selective estrogen receptor modulators for schizophrenia and related psychotic disorders has completed.
-
CLINICAL_TRIALS trial_result · 2007-01-29Clinical Trial Update: Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety [Phase 4]
Phase 4 trial of aripiprazole for schizophrenia with co-morbid social anxiety completed.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder [Phase 4]
Phase 4 trial results evaluating high-dose olanzapine for schizophrenia and schizoaffective disorder have been completed, according to the u…
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: A Comparative Study of New Medications for Psychosis in Adolescents [NA]
This clinical trial update reports the completion of a comparative study evaluating new medications for psychosis in adolescents. The study …
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Pharmacokinetic Characterization of Intramuscular Olanzapine Depot [Phase 1]
Phase 1 clinical trial update characterizing the pharmacokinetics of intramuscular olanzapine depot (olanzapine pamoate) in schizophrenia an…
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia [Phase 4]
A Phase 4 trial comparing olanzapine to an active comparator in depression associated with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder [Phase 4]
Phase 4 trial completed evaluating a weight-gain agent for treating olanzapine-associated weight gain in patients with schizophrenia, schizo…